Henry Yampolsky, M.D.
"Dr. Yampolsky is a wonderful doctor and an even nicer human being who made me feel confident and comfortable every step of the way." - Patient
Henry Yampolsky, M.D., is one of only a few Russian-speaking radiation oncologists in the United States. He grew up in the former Soviet Union where he studied computer science at one of the most prestigious universities in Moscow. After immigrating to the United States in 1992, Dr. Yampolsky graduated from the University of California Los Angeles with a B.S. in Biochemistry. He received his M.D. degree from the University of Southern California.
A board-certified radiation oncologist, Dr. Yampolsky completed his radiation oncology specialty training at USC Norris Comprehensive Cancer Center and LAC+USC Medical Center. While at USC, Dr. Yampolsky acquired broad clinical expertise in the treatment of cancer, as well as extensive experience with intensity modulated radiation therapy (IMRT) and stereotactic radiotherapy.
West Hills Radiation Oncology
Suite 100
West Hills, CA 91307
2007, American Board of Radiology
2001, M.D., University of Southern California School of Medicine, Los Angeles, CA
1997, B.S., Biochemistry, University of California Los Angeles, Los Angeles, CA
2002 - 2006, Radiation Oncology, University of Southern California, Los Angeles, CA
2001 - 2002, Pediatrics, Kaiser Permanente, Los Angeles, CA
2018 - present, Radiation Oncologist and Assistant Clinical Professor, Department of Radiation Oncology, City of Hope, West Hills, CA
2014 - 2018, West Hills Radiation Therapy Center, West Hills, CA
2007 - present, Radiation Oncologist, Center for Radiation Therapy of Beverly Hills, Beverly Hills, CA
2005, American Society for Therapeutic Radiology and Oncology
2005, American Society for Clinical Oncology
2005, Board Member, American Russian Medical Association, Los Angeles, CA
2002, California Radiation Oncology Society
1998, Member of the Campus Committee, Jewish Federation, Nashville, TN
- Douer D, Yampolsky H, Cohen LJ, Periciou LA, Watkins K, Levine AM, Avramis VI. PEG-Asparaginase In A Remission Induction Regimen For Newly Diagnosed Adult Acute Lymphoblastic Leukemia, Blood; 2006 Nov 28
- Watkins K, Avramis V, Douer D. The Use Of Peg-Asparaginase instead of E.Colk L-Asparaginase In A Remission Induction Regimen For Newly Diagnosed Adult Acute Lymphoblastic Leukemia. Departments of Medicine and Pediatrics, USC School of Medicine, Los Angeles (presented at the Medical Student Research Forum 2000, University of Southern California School of Medicine).
- Douer D, Cohen LJ, Periciou LA, Yampolsky H, Watkins K, Levine AM, Avramis VI. Peg-Asparaginase In A Remission Induction Regimen For Newly Diagnosed Adult Acute Lymphoblastic Leukemia. Departments of Medicine and Pediatrics, USC School of Medicine
- Los Angeles, CA; Blood 1998 92(10)suppl 1:400a (presented at the annual meeting of the American Society of Hematology 1998).